Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

November 2018
1. WANG H, Sun Y
   Further insight into the impact of the NLA guideline, ESC guideline, and AACE/ACE guideline on LDL-cholesterol target achievement: Time to rethink the strategy?
   Int J Cardiol. 2018;271:347.
   PubMed     Text format    
   
   
   October 2018
2. FUKUMOTO Y
   Impact of statin-ezetimibe combination in chronic kidney disease.
   Int J Cardiol. 2018;268:36-37.
   PubMed     Text format    
   
   
   September 2018
3. KUMAR R, Tonkin A, Liew D, Zomer E, et al
   The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.
   Int J Cardiol. 2018;267:183-187.
   PubMed     Text format     Abstract available
   
   
   
4. WON KB, Han D, Lee JH, Lee SE, et al
   Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes.
   Int J Cardiol. 2018;266:250-253.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. YAN BP, Chiang FT, Ambegaonkar B, Brudi P, et al
   Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
   Int J Cardiol. 2018;265:1-5.
   PubMed     Text format     Abstract available
   
   
   
6. BECKOWSKI M, Gierlotka M, Gasior M, Polonski L, et al
   Risk factors predisposing to acute coronary syndromes in young women </=45years of age.
   Int J Cardiol. 2018;264:165-169.
   PubMed     Text format     Abstract available
   
   
   July 2018
7. LIBERALE L, Carbone F, Bertolotto M, Bonaventura A, et al
   Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis.
   Int J Cardiol. 2018;263:138-141.
   PubMed     Text format     Abstract available
   
   
   June 2018
8. HERMANN M, Witassek F, Erne P, Radovanovic D, et al
   Referral for cardiac rehabilitation after acute myocardial infarction: Insights from nationwide AMIS Plus registry 2005-2017.
   Int J Cardiol. 2018;261:1-5.
   PubMed     Text format     Abstract available
   
   
   
9. KUWABARA M, Borghi C, Cicero AFG, Hisatome I, et al
   Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan.
   Int J Cardiol. 2018;261:183-188.
   PubMed     Text format     Abstract available
   
   
   
10. ZHANG M, Deng Q, Wang L, Huang Z, et al
    Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.
    Int J Cardiol. 2018;260:196-203.
    PubMed     Text format     Abstract available
    
    
    May 2018
11. SHIN D, Kongpakpaisarn K, Bohra C
    Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014.
    Int J Cardiol. 2018;259:216-219.
    PubMed     Text format     Abstract available
    
    
    March 2018
12. FREISINGER E, Malyar NM, Reinecke H, Unrath M, et al
    Low rate of revascularization procedures and poor prognosis particularly in male patients with peripheral artery disease - A propensity score matched analysis.
    Int J Cardiol. 2018;255:188-194.
    PubMed     Text format     Abstract available
    
    
    
13. CANEPA M, Artom N, Ameri P, Carbone F, et al
    Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia.
    Int J Cardiol. 2018;255:215-220.
    PubMed     Text format    
    
    
    
14. MACHADO LBM, Silva BLS, Garcia AP, Oliveira RAM, et al
    Ideal cardiovascular health score at the ELSA-Brasil baseline and its association with sociodemographic characteristics.
    Int J Cardiol. 2018;254:333-337.
    PubMed     Text format     Abstract available
    
    
    
15. FEDELI U, Avossa F, Ferroni E, Schievano E, et al
    Diverging patterns of cardiovascular diseases across immigrant groups in Northern Italy.
    Int J Cardiol. 2018;254:362-367.
    PubMed     Text format     Abstract available
    
    
    February 2018
16. GUPTA R, Singh Y
    Treatment gaps in severe hypercholesterolemia.
    Int J Cardiol. 2018;252:199-200.
    PubMed     Text format    
    
    
    
17. FAGGIANO P, Pirillo A, Griffo R, Ambrosetti M, et al
    Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Int J Cardiol. 2018;252:193-198.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. LIN XL, Liu MH
    Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol.
    Int J Cardiol. 2017;247:49.
    PubMed     Text format    
    
    
    March 2017
19. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available
    
    
    February 2017
20. DUFOUR R, Bergeron J, Gaudet D, Weiss R, et al
    Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
    Int J Cardiol. 2017;228:754-760.
    PubMed     Text format     Abstract available
    
    
    January 2017
21. LIN PY, Lee FY, Wallace CG, Chen KH, et al
    The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness.
    Int J Cardiol. 2017;227:938-949.
    PubMed     Text format     Abstract available
    
    
    
22. HU D, Yang Y, Peng DQ
    Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Int J Cardiol. 2017;227:61-65.
    PubMed     Text format     Abstract available
    
    
    
23. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available
    
    
    November 2016
24. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Text format     Abstract available
    
    
    August 2016
25. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Text format     Abstract available
    
    
    
26. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available
    
    
    July 2016
27. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available
    
    
    June 2016
28. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Text format     Abstract available
    
    
    
29. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available
    
    
    
30. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Text format     Abstract available
    
    
    May 2016
31. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Text format     Abstract available
    
    
    April 2016
32. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Text format     Abstract available
    
    
    March 2016
33. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.
    PubMed     Text format    
    
    
    January 2016
34. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    
    
    
    
35. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.
    PubMed     Text format    
    
    
    
36. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.
    PubMed     Text format    
    
    
    
37. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: